Parametric Portfolio Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $30.9M | Sell |
|
|||||
|
2021
Q4 | $34.9M | Sell |
|
|||||
|
2021
Q3 | $39.4M | Buy |
|
|||||
|
2021
Q2 | $33.7M | Buy |
|
|||||
|
2021
Q1 | $25.5M | Buy |
|
|||||
|
2020
Q4 | $21.3M | Buy |
|
|||||
|
2020
Q3 | $22.4M | Sell |
|
|||||
|
2020
Q2 | $24M | Buy |
|
|||||
|
2020
Q1 | $16.8M | Buy |
|
|||||
|
2019
Q4 | $16.3M | Sell |
|
|||||
|
2019
Q3 | $15.9M | Buy |
|
|||||
|
2019
Q2 | $11.1M | Buy |
|
|||||
|
2019
Q1 | $13.1M | Buy |
|
|||||
|
2018
Q4 | $7.12M | Buy |
|
|||||
|
2018
Q3 | $8.11M | Buy |
|
|||||
|
2018
Q2 | $7.74M | Sell |
|
|||||
|
2018
Q1 | $9.42M | Buy |
|
|||||
|
2017
Q4 | $9.43M | Buy |
|
|||||
|
2017
Q3 | $7.44M | Sell |
|
|||||
|
2017
Q2 | $5.11M | Buy |
|
|||||
|
2017
Q1 | $3.08M | Buy |
|
|||||
|
2016
Q4 | $1.31M | Sell |
|
|||||
|
2016
Q3 | $3.12M | Buy |
|
|||||
|
2016
Q2 | $2.11M | Buy |
|
|||||
|
2016
Q1 | $1.69M | Sell |
|
|||||
|
2015
Q4 | $3.73M | Buy |
|
|||||
|
2015
Q3 | $2.43M | Sell |
|
|||||
|
2015
Q2 | $4.41M | Buy |
|
|||||
|
2015
Q1 | $2.99M | Buy |
|
|||||
|
2014
Q4 | $2.36M | Buy |
|
|||||
|
2014
Q3 | $1.05M | Buy |
|
|||||
|
2014
Q2 | $819K | Sell |
|
|||||
|
2014
Q1 | $1.41M | Sell |
|
|||||
|
2013
Q4 | $1.38M | Sell |
|
|||||
|
2013
Q3 | $1.55M | Sell |
|
|||||
|
2013
Q2 | $839K | Buy |
|